TEXTILOMA RESEMBLING ANAPLASTIC PROGRESSION OF AN IDH1 MUTANT, LOW-GRADE GLIOMA

被引:0
|
作者
Anderson, Mark D. [1 ]
Raghunathan, Aditya [1 ]
Aldape, Kenneth D. [1 ]
Fuller, Greg N. [1 ]
Gilbert, Mark R. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:67 / 67
页数:1
相关论文
共 50 条
  • [41] DIRECT IN VIVO CRISPR SCREEN IDENTIFIES COOPERATING TUMOR SUPPRESSORS THAT DRIVE PROGRESSION OF IDH1-MUTANT LOW-GRADE GLIOMA TO AGGRESSIVE GLIOBLASTOMA
    Yanchus, Connor
    Drucker, Kristen
    Kollmeyer, Thomas
    Tsai, Ricky
    Jiang, Lingyan
    Ali, Asma
    Carson, Brittany
    Pawling, Judy
    Malik, Ahmad
    Al-Zahrani, Khalid
    Loganathan, Sampath Kumar
    Fortin, Jerome
    Zhou, Lily
    Elia, Andrew
    Dennis, James W.
    Mak, Tak
    Taylor, Michael
    Zadeh, Gelareh
    Dirks, Peter
    Jenkins, Robert
    Schramek, Daniel
    NEURO-ONCOLOGY, 2021, 23 : 219 - 219
  • [42] IDH1 mutation is associated with seizures and protoplasmic subtype in patients with low-grade gliomas
    Liubinas, Simon V.
    D'Abaco, Giovanna M.
    Moffat, Bradford M.
    Gonzales, Michael
    Feleppa, Frank
    Nowell, Cameron J.
    Gorelik, Alexandra
    Drummond, Katharine J.
    O'Brien, Terence J.
    Kaye, Andrew H.
    Morokoff, Andrew P.
    EPILEPSIA, 2014, 55 (09) : 1438 - 1443
  • [43] Comparison of Transcriptomic Analysis between IDH1 Mutant and Wild-type of Lower Grade Glioma
    Lee, MinWook
    Jin, Hoeyoung
    Kim, Suwan
    Ji, SeonYeong
    Song, SeokJung
    Koh, DooHyun
    Choi, JoungWan
    Park, JeongMan
    Lee, YunGyeon
    Jo, GaeHoon
    Kim, JongIl
    Sim, JeongMin
    Ahn, JuWon
    Park, YoungJoon
    Kwack, KyuBum
    FASEB JOURNAL, 2020, 34
  • [44] IDH1 mutation is associated with a higher preoperative seizure incidence in low-grade glioma: A systematic review and meta-analysis
    Li, Yucai
    Shan, Xia
    Wu, Zhifeng
    Wang, Yinyan
    Ling, Miao
    Fan, Xing
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2018, 55 : 76 - 82
  • [45] Combined IDH1 mutation and MGMT methylation status on long-term survival of patients with cerebral low-grade glioma
    Tanaka, Kazuhiro
    Sasayama, Takashi
    Mizukawa, Katsu
    Takata, Kumi
    Sulaiman, Nor Shazrina
    Nishihara, Masamitsu
    Kohta, Masaaki
    Sasaki, Ryohei
    Hirose, Takanori
    Itoh, Tomoo
    Kohmura, Eiji
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2015, 138 : 37 - 44
  • [46] IDH1 EXPRESSION CORRELATES WITH INCIDENCE OF PREOPERATIVE SEIZURES IN PATIENTS WITH LOW-GRADE GLIOMAS
    Liubinas, Simon V.
    D'Abaco, Giovanna M.
    Moffat, Bradford
    Gonzales, Michael
    Feleppa, Frank
    Nowell, Cameron J.
    Gorelick, Alexandra
    Drummond, Katharine J.
    Morokoff, Andrew P.
    O'Brien, Terence J.
    Kaye, Andrew H.
    NEURO-ONCOLOGY, 2013, 15 : 119 - 119
  • [47] Author Correction: Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial
    Ingo K. Mellinghoff
    Min Lu
    Patrick Y. Wen
    Jennie W. Taylor
    Elizabeth A. Maher
    Isabel Arrillaga-Romany
    Katherine B. Peters
    Benjamin M. Ellingson
    Marc K. Rosenblum
    Saewon Chun
    Kha Le
    Ania Tassinari
    Sung Choe
    Youssef Toubouti
    Steven Schoenfeld
    Shuchi S. Pandya
    Islam Hassan
    Lori Steelman
    Jennifer L. Clarke
    Timothy F. Cloughesy
    Nature Medicine, 2024, 30 : 302 - 302
  • [48] IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas
    Houillier, C.
    Wang, X.
    Kaloshi, G.
    Mokhtari, K.
    Guillevin, R.
    Laffaire, J.
    Paris, S.
    Boisselier, B.
    Idbaih, A.
    Laigle-Donadey, F.
    Hoang-Xuan, K.
    Sanson, M.
    Delattre, J. -Y.
    NEUROLOGY, 2010, 75 (17) : 1560 - 1566
  • [49] Duchenne muscular dystrophy gene expression is an independent prognostic marker for IDH mutant low-grade glioma
    Michael Naidoo
    Leanne Jones
    Benjamin Conboy
    Wael Hamarneh
    Darwin D’Souza
    Karen Anthony
    Lee R. Machado
    Scientific Reports, 12
  • [50] Is intracranial volume a risk factor for IDH-mutant low-grade glioma? A case–control study
    Lisa Millgård Sagberg
    Even Hovig Fyllingen
    Tor Ivar Hansen
    Per Sveino Strand
    Aril Løge Håvik
    Terje Sundstrøm
    Alba Corell
    Asgeir Store Jakola
    Øyvind Salvesen
    Ole Solheim
    Journal of Neuro-Oncology, 2022, 160 : 101 - 106